[pending] Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
Pending LLM rewrite. Source: CPSC 26157.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
The recalled product
- Product
- Mamisan Pain Relieving Topical Ointment
- Manufacturer
- MiramarLab, of Doral, Florida
- Category
- Consumer Product
- Affected units
- 50,330
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 860006498115
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereE-Bike Batteries Recalled After 27 Fire Reports, 4 Injuries
CPSC · 2026-08-07
- High
- Severe
- SeverePool Drain Covers Recalled for Entrapment and Drowning Hazards
CPSC · 2026-06-04
- Severe